Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway
Biochemical Pharmacology · 2023-02 · 208 · 115371
DOI: 10.1016/j.bcp.2022.115371 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2023-02. Verfasst von Natalie C Sondermann und 6 weiteren Autor:innen. Beteiligte Einrichtung: IUF - Leibniz Research Institute for Environmental Medicine, 40225 Düsseldorf, Germany. Hauptthemen laut MEDLINE: Aryl Hydrocarbon Receptor Nuclear Translocator, Receptors, Aryl Hydrocarbon. Die Arbeit wurde bisher 200-mal zitiert (Crossref) und nennt 334 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, National Institute of Environmental Health Sciences, Jürgen Manchot Stiftung.
Abstract (Originalsprache)
The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor regulating adaptive and maladaptive responses toward exogenous and endogenous signals. Research from various biomedical disciplines has provided compelling evidence that the AHR is critically involved in the pathogenesis of a variety of diseases and disorders, including autoimmunity, inflammatory diseases, endocrine disruption, premature aging and cancer. Accordingly, AHR is considered an attractive target for the development of novel preventive and therapeutic measures. However, the ligand-based targeting of AHR is considerably complicated by the fact that the receptor does not always follow the beaten track, i.e. the canonical AHR/ARNT signaling pathway. Instead, AHR might team up with other transcription factors and signaling molecules to shape gene expression patterns and associated physiological or pathophysiological functions in a ligand-, cell- and micromilieu-dependent manner. Herein, we provide an overview about some of the most important non-canonical functions of AHR, including crosstalk with major signaling pathways involved in controlling cell fate and function, immune responses, adaptation to low oxygen levels and oxidative stress, ubiquitination and proteasomal degradation. Further research on these diverse and exciting yet often ambivalent facets of AHR biology is urgently needed in order to exploit the full potential of AHR modulation for disease prevention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IUF - Leibniz Research Institute for Environmental Medicine, 40225 Düsseldorf, Germany.
- Department of Environmental Toxicology and Center for Health and the Environment, University of California, Davis, CA 95616, USA.
- IUF - Leibniz Research Institute for Environmental Medicine, 40225 Düsseldorf, Germany. Electronic address: thomas.haarmann-stemmann@iuf-duesseldorf.de.
Förderung
- NIEHS NIH HHS
- National Institute of Environmental Health Sciences
- Jürgen Manchot Stiftung
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
Zitieren
APA
Sondermann, N. C., Faßbender, S., Hartung, F., Hätälä, A. M., Rolfes, K. M., Vogel, C. F. A., & Haarmann-Stemmann, T. (2023). Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway. Biochemical Pharmacology, 208, 115371. https://doi.org/10.1016/j.bcp.2022.115371
Vancouver
Sondermann NC, Faßbender S, Hartung F, Hätälä AM, Rolfes KM, Vogel CFA, et al. Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway. Biochemical Pharmacology. 2023;208:115371. doi:10.1016/j.bcp.2022.115371
BibTeX
@article{Sondermann2023,
author = {Sondermann, Natalie C and Faßbender, Sonja and Hartung, Frederick and Hätälä, Anna M and Rolfes, Katharina M and Vogel, Christoph F A and Haarmann-Stemmann, Thomas},
title = {Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway},
journal = {Biochemical Pharmacology},
year = {2023},
volume = {208},
pages = {115371},
doi = {10.1016/j.bcp.2022.115371}
}
EUVIMED